Mareque M, Montesinos P, Font P, Guinea JM, de la Fuente A, Soto J, Oyagüez I, Brockbank J, Iglesias T, Llinares J, Sierra J

Mareque M, Montesinos P, Font P, Guinea JM, de la Fuente A, Soto J, Oyagüez I, Brockbank J, Iglesias T, Llinares J, Sierra J

 

 

Cost-effectiveness analysis of gemtuzumab ozogamicin for first-line treatment of patients with CD-33 positive acute myeloid leukaemia in Spain

ClinicoEconomics and Outcomes Research 2021; 13:263-277